Delos Santos, Jaylou R.

HRN: 28-56-84  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/22/2026
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
02/22/2026
03/01/2026
IV
500
Q12
Klebsiella Pneumoniae
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: